For example, in the Berkeley mouse model of SCD, rivaroxaban attenuated systemic inflammation by decreasing plasma levels of IL-6, whereas dabigatran did not significantly affect IL-6 levels but impacted neutrophil infiltration in the lung, delineating their specific pathways of action [277]. Here, IL6 is linked to Schnyder corneal dystrophy.